Synthesis, crystal structures, and biological evaluation of manganese(II) and nickel(II) complexes of 4-cyclohexyl-1-(1-(pyrazin-2-yl)ethylidene)thiosemicarbazide

Techniques in the synthesis of mononuclear manganese complexes: a review

This article describes an overview of the synthetic techniques and protocols for the preparation of new ligands and respective manganese (Mn) complexes to be tested for biomedical applications. Mn is an essential and biocompatible element, the complexes of which have diverse medicinal applications. The most significant use of Mn complexes is their application against reactive oxygen species in biological systems, and due to this, three Mn-incorporated complexes (AEOL-10150, EUK-134, and M40403) are already under clinical trials. Hence, the interest in synthesizing biologically active Mn complexes is rapidly increasing. Mn complexes are commonly synthesized using either water or ethanol as a reaction medium for their possible usage in biological systems. Using common Mn salts along with suitable organic ligand works well in the presence of little heat to obtain Mn complexes of interest.

Synthesis, structural characterization, QSAR and docking studies of a new binuclear nickel (II) complex based on the flexible tetradentate N-donor ligand as a potent antibacterial and anticancer agent

A new nickel (II)complex namely [Ni₂(Lt)Cl₄] derived from the NiCl₂.6H₂O and 1,1,3,3-tetrakis(3,5-dimethyl-1-pyrazolyl)propane (Lt) has been synthesized and fully characterized by the single crystal X-ray diffraction, elemental analysis, FT-IR, UV-vis, density functional theory (DFT) calculations, antibacterial and anticancer activities. In the title complex, each of the Ni(II) atoms is tetrahedrally coordinated by two N atoms from one of the chelating bidentate bis(3,5-dimethylpyrazolyl)methane units of the Lt ligand and two Cl as terminal ligands. The neighboring [Ni₂(Lt)Cl₄] molecules are linked together by the intermolecular CH⋯Cl hydrogen bonds to generate a 1D chain structure. The chains are further stabilized by the intermolecular CH⋯π interactions to form a two-dimensional non-covalent bonded structure. The antibacterial activity of the free Lt ligand and its Ni (II) complex shows that the ability of these compounds to inhibit growth of the tested bacteria increase from the Lt to binuclear nickel (II) complex. Scanning probe microscopy (SPM) study of the treated B. subtilis and E. coli bacteria was implemented to understand the structural changes caused by the interactions between the nickel (II) complex and the target bacteria. The cytotoxicity test of the Lt ligand and its complex was evaluated against the human carcinoma cell line (Caco-2) using the MTT assay. The results indicate that the Lt ligand and its complex display cytotoxicity against Caco-2 with the IC50 values of 36.29μM and 12.97μM, respectively. Therefore, the complex can be nominated as a potential anticancer agent. Molecular docking investigations on the five standard antibiotic, five standard anticancer drugs, free Lt ligand, title complex and twelve receptors were performed by Autodock vina function. The results of docking and DFT calculations are in line with the in vitro data obtained via the antibacterial and anticancer activity of Lt ligand and its made-complex.

Design and synthesis of novel N()-substituted thiosemicarbazones bearing a pyrrole unit as potential anticancer agents

A series of N(4)-substituted thiosemicarbazones (TSCs) bearing pyrrole unit (1a-1e) were synthesized and fully characterized by elemental analyses, infrared spectra, ¹H nuclear magnetic resonance and single crystal X-ray diffraction. The compounds were assessed as potential chemotherapeutic agents. All newly synthesized compounds were screened for their anticancer activity against lung cancer PC-9, esophageal cancer Eca-109 and gastric cancer SGC-7901 cell lines. The results of MTT, Terminal deoxynucleotidyl transferase dUTP nick end labeling and fluorescence-activated cell sorting assays indicated that all the prepared compounds exhibited cytotoxicity against PC-9, Eca-109 and SGC-7901 cells in vitro. All the compounds significantly induced cancer cell apoptosis accompanied by increasing the Bax/Bcl-2 ratio and activation of caspase-3. The structure-activity association was discussed and the potential pre-clinical trials may be conducted. The present findings have a great potential in biomedical applications of novel N(4)-substituted TSCs.

Main group bismuth(III), gallium(III) and diorganotin(IV) complexes derived from bis(2-acetylpyrazine)thiocarbonohydrazone: synthesis, crystal structures and biological evaluation

Up to now, the metal complexes with thiocarbonohydrazones have been comparatively rare. Herein, three main group monometallic complexes formulated as [Bi(HL)(NO3)2(H2O)] (1), [Ga(HL)2]OAc·EtOH (2) and [(Ph)2Sn(HL)(OAc)]·DMF (3), where H2L = bis(2-acetylpyrazine)thiocarbonohydrazone, have been synthesized and characterized. The crystal structures of complexes 2 and 3 have been determined by single-crystal X-ray diffraction. Growth inhibition assays have indicated that both the free ligand and the title complexes are capable of inhibiting cell proliferation growth and could slightly distinguish the human hepatocellular carcinoma HepG2 cells from normal hepatocyte QSG7701 cells. Of particular note is the fact that the bismuth(III) complex 1 is the most active compound of this study and is 14-fold more cytotoxic than H2L with an IC50 value of 2.96 ± 0.25 μM. Its possible apoptotic mechanism has been evaluated in HepG2 cells. Complex 1 promotes a dose-dependent apoptosis in HepG2 cells and the apoptosis is associated with an increase in intracellular reactive oxygen species (ROS) production and reduction of mitochondrial membrane potential (MMP).

A chiral, low-cytotoxic [Ni15]-wheel complex

A new chiral [Ni15] complex with a Schiff-base ligand derived from o-vanillin and L-glutamic acid is presented, emphasizing the properties relevant for biology and materials science. The formation of the complex molecules in solution is confirmed by AFM and dynamic light scattering studies. The compound is weakly antiferromagnetic with considerable admixture of excited states, comprising negligibly interacting [Ni3] units. Studies of the interactions with two cell lines indicate low cytotoxicity.

Spectral, thermal and biological studies of Mn(II) and Cu(II) complexes with two thiosemicarbazide derivatives

Two derivatives of thiosemicarbazide were prepared. Their complexes were prepared using Mn(II) and Cu(II) salts. All the isolated complexes are characterized using the following spectra: IR, UV-Vis, Mass, (1)H NMR and X-ray diffraction. Magnetic measurements and thermal analysis are the other additive tools for complete investigation. Mononuclear and binuclear complexes are proposed based on elemental analysis mainly. The IR spectra offer the mode of coordination of each ligand with each metal ion. The electronic spectra and magnetic measurements are proposing the structural geometry of the investigated complexes. The octahedral geometry proposed for Mn(II) complexes but the square-planar for Cu(II) complexes. The (1)H NMR spectra were done for all organic compounds used in this study and displaying the most suitable tautomer of them. X-ray diffraction of H(2)L(1) and its complexes show their amorphous nature but H(2)L(2) ligand and its complexes show their nanocrystalline nature. The TG analysis was used to prove the presence of solvent molecules attached with the complexes as covalently or physically. Finally, the biological investigation was carried out for H(2)L(2) ligand and its complexes and displaying the inhibition activity of Cu(II) complex than the Mn(II) one.